Free Trial
ASX:AGN

Argenica Therapeutics (AGN) Stock Price, News & Analysis

About Argenica Therapeutics Stock (ASX:AGN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$104.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Argenica Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

AGN Stock News Headlines

Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.
ASX Penny Stock Highlights For May 2025
Argenica Therapeutics Ltd Ordinary Shares AGN
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Insurance
Current Symbol
ASX:AGN
CIK
N/A
Fax
N/A
Employees
22,300
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$5.48 million
Net Margins
-238.05%
Pretax Margin
N/A
Return on Equity
-60.20%
Return on Assets
-27.35%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.75
Quick Ratio
12.21

Sales & Book Value

Annual Sales
A$2.60 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
A$0.13 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
128,090,000
Free Float
N/A
Market Cap
A$104.40 million
Optionable
Not Optionable
Beta
0.79
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (ASX:AGN) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners